Claritev Corp. (CTEV)
39.35
-0.48
(-1.21%)
USD |
NYSE |
Sep 01, 16:00
40.44
+1.09
(+2.77%)
Pre-Market: 09:02
Claritev Cash from Investing (Quarterly) : -38.08M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -38.08M |
| March 31, 2026 | -46.77M |
| December 31, 2025 | -34.66M |
| September 30, 2025 | -22.87M |
| June 30, 2025 | -24.62M |
| March 31, 2025 | -38.87M |
| December 31, 2024 | -30.43M |
| September 30, 2024 | -31.70M |
| June 30, 2024 | -25.44M |
| March 31, 2024 | -30.54M |
| December 31, 2023 | -31.34M |
| September 30, 2023 | -22.06M |
| June 30, 2023 | -173.29M |
| Date | Value |
|---|---|
| March 31, 2023 | -23.10M |
| December 31, 2022 | -25.53M |
| September 30, 2022 | -20.81M |
| June 30, 2022 | -33.94M |
| March 31, 2022 | -24.16M |
| December 31, 2021 | -27.18M |
| September 30, 2021 | -20.35M |
| June 30, 2021 | -18.45M |
| March 31, 2021 | -162.40M |
| December 31, 2020 | -60.52M |
| September 30, 2020 | -115.46M |
| June 30, 2020 | -17.53M |
| March 31, 2020 | -17.34M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| LataMed AI Corp. | 0.00 |
| SCWorx Corp. | -0.0726M |
| Health Catalyst, Inc. | 0.902M |
| GoodRx Holdings, Inc. | -14.41M |
| iSpecimen, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 92.67M |
| Cash from Financing (Quarterly) | -61.64M |
| Free Cash Flow | -17.92M |
| Free Cash Flow Per Share (Quarterly) | 3.218 |
| Free Cash Flow to Equity (Quarterly) | 96.74M |
| Free Cash Flow to Firm (Quarterly) | 130.62M |
| Free Cash Flow Yield | -2.73% |